Loading…

Bleb Morphology and Vascularity After Trabeculectomy With Intravitreal Ranibizumab: A Pilot Study

Purpose To investigate outcomes after trabeculectomy using intraoperative intravitreal ranibizumab and topical mitomycin C (MMC) vs MMC alone. Design Prospective randomized single-site pilot study. Methods Patients diagnosed with primary open-angle glaucoma were randomized 1:1 to either combination...

Full description

Saved in:
Bibliographic Details
Published in:American journal of ophthalmology 2010-09, Vol.150 (3), p.399-403.e1
Main Author: Kahook, Malik Y
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose To investigate outcomes after trabeculectomy using intraoperative intravitreal ranibizumab and topical mitomycin C (MMC) vs MMC alone. Design Prospective randomized single-site pilot study. Methods Patients diagnosed with primary open-angle glaucoma were randomized 1:1 to either combination intravitreal ranibizumab 0.5 mg and topically applied MMC (0.4 mg/mL for 2 min) or MMC (0.4 mg/mL for 2 min) therapy alone at time of trabeculectomy surgery. The primary endpoint measured was bleb morphology and vascularity using the Moorfields Bleb Grading System. Unqualified success was defined as postoperative intraocular pressure (IOP) of >5 and 5 and
ISSN:0002-9394
1879-1891
DOI:10.1016/j.ajo.2010.03.025